| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1992PNAS...89..524T |
| P356 | DOI | 10.1073/PNAS.89.2.524 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC48271 |
| https://europepmc.org/articles/PMC48271?pdf=render | ||
| https://pnas.org/doi/pdf/10.1073/pnas.89.2.524 | ||
| P932 | PMC publication ID | 48271 |
| P698 | PubMed publication ID | 1731324 |
| P5875 | ResearchGate publication ID | 21425112 |
| P2093 | author name string | J. L. Brunton | |
| B. Toye | |||
| K. Ramotar | |||
| B. Boyd | |||
| C. A. Lingwood | |||
| G. J. Tyrrell | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| A rapid alkaline extraction procedure for screening recombinant plasmid DNA | Q24614998 | ||
| Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities | Q24646436 | ||
| Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa | Q27861105 | ||
| Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril | Q29618344 | ||
| The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli | Q33457864 | ||
| Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype | Q34256166 | ||
| Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis. | Q34372184 | ||
| Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine | Q36215407 | ||
| Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. | Q36265701 | ||
| The human c-fps/fes gene product expressed ectopically in rat fibroblasts is nontransforming and has restrained protein-tyrosine kinase activity | Q36782634 | ||
| Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants | Q36977977 | ||
| Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies | Q36997934 | ||
| Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli | Q37031424 | ||
| Modification of the glycolipid-binding specificity of vero cytotoxin by polymyxin B and other cyclic amphipathic peptides | Q40154302 | ||
| Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. | Q40165986 | ||
| Quantitative microtiter cytotoxicity assay for Shigella toxin. | Q40230921 | ||
| Effects of Escherichia coli Shiga-like toxins (verotoxins) in pigs | Q41295987 | ||
| Cloning and nucleotide sequence analysis of the genes determining verocytotoxin production in a porcine edema disease isolate of Escherichia coli | Q42653384 | ||
| Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron | Q42859529 | ||
| Simultaneous fractionation of four placental neutral glycosphingolipids with a continuous gradient. | Q51181154 | ||
| Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. | Q54385143 | ||
| Verotoxin receptor glycolipid in human renal tissue. | Q54736253 | ||
| Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. | Q54764104 | ||
| Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function | Q67913265 | ||
| Globotetraosylceramide is recognized by the pig edema disease toxin | Q69517260 | ||
| Identification of the uvrA gene product | Q72915605 | ||
| Sensitive mutants of bacteriophage lambda | Q78804683 | ||
| P4510 | describes a project that uses | site-directed mutagenesis | Q2642668 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 524-528 | |
| P577 | publication date | 1992-01-01 | |
| 1992-01-15 | |||
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit | |
| P478 | volume | 89 |
| Q27622010 | A mutant Shiga-like toxin IIe bound to its receptor Gb(3): structure of a group II Shiga-like toxin with altered binding specificity |
| Q42941754 | Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs |
| Q35586936 | Analysis of Shiga toxin subunit association by using hybrid A polypeptides and site-specific mutagenesis |
| Q40444022 | Bcl-2 antiapoptotic protein mediates verotoxin II-induced cell death: possible association between bcl-2 and tissue failure by E. coli O157:H7. |
| Q90131552 | Bimodal Response to Shiga Toxin 2 Subtypes Results from Relatively Weak Binding to the Target Cell |
| Q37036097 | Binding of Pk-trisaccharide analogs of globotriaosylceramide to Shiga toxin variants. |
| Q39824731 | Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors. |
| Q36363421 | CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis |
| Q34999780 | Development of monoclonal antibodies and immunoassays for sensitive and specific detection of Shiga toxin Stx2f |
| Q72996597 | Development of recombinant B subunit of Shiga-like toxin 1 as a probe to detect carbohydrate ligands in immunochemical and flowcytometric application |
| Q54658182 | Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls. |
| Q33337469 | Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells |
| Q39515881 | Enterohemorrhagic Escherichia coli induces apoptosis which augments bacterial binding and phosphatidylethanolamine exposure on the plasma membrane outer leaflet. |
| Q39529333 | Enteropathogenic Escherichia coli virulence factor bundle-forming pilus has a binding specificity for phosphatidylethanolamine. |
| Q39655730 | Escherichia coli shiga-like toxins induce apoptosis and cleavage of poly(ADP-ribose) polymerase via in vitro activation of caspases |
| Q24633154 | Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro |
| Q30655292 | Expression cloning of human globoside synthase cDNAs. Identification of beta 3Gal-T3 as UDP-N-acetylgalactosamine:globotriaosylceramide beta 1,3-N-acetylgalactosaminyltransferase. |
| Q48220960 | Genetic and Immunological Analysis of a Novel Variant of Shiga Toxin 1 from Bovine Escherichia coli Strains and Development of Bead‐ELISA to Detect the Variant Toxin |
| Q35199053 | Glycolipid binding preferences of Shiga toxin variants |
| Q41993044 | Glycolipid modification of α2 interferon binding. Sequence similarity between the α2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit |
| Q38331987 | Identification of a novel streptococcal adhesin P (SadP) protein recognizing galactosyl-α1-4-galactose-containing glycoconjugates: convergent evolution of bacterial pathogens to binding of the same host receptor |
| Q54646115 | Increased globotriaosylceramide on plasma membranes of synchronized familial dysautonomia cells. Verotoxin binding studies. |
| Q39522797 | Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili |
| Q57363615 | Lipid Modulation of Glycosphingolipid (GSL) Receptors: Soluble GSL Mimics Provide New Probes of GSL Receptor Function |
| Q35551789 | Murine antibody responses to the verotoxin 1 B subunit: demonstration of major histocompatibility complex dependence and an immunodominant epitope involving phenylalanine 30 |
| Q39857916 | Neutral red assay for measurement of quantitative vero cell cytotoxicity |
| Q29620102 | OB(oligonucleotide/oligosaccharide binding)-fold: common structural and functional solution for non-homologous sequences |
| Q42679053 | Overexpression and biochemical characterization of beta-1,3-N-acetylgalactosaminyltransferase LgtD from Haemophilus influenzae strain Rd. |
| Q24550740 | Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections |
| Q40670522 | Principles of glycosphingolipid-oligosaccharide constitution. |
| Q30699689 | Probing the surface of eukaryotic cells using combinatorial toxin libraries |
| Q28488900 | Purification and characterization of Shiga toxin 2f, an immunologically unrelated subtype of Shiga toxin 2 |
| Q34739913 | Shiga toxin subtypes display dramatic differences in potency |
| Q35068024 | Simple method for Shiga toxin 2e purification by affinity chromatography via binding to the divinyl sulfone group |
| Q40552744 | The P blood group system: biochemical, serological, and clinical aspects |
| Q35773392 | The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality |
| Q39829974 | Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits. |
| Q40782927 | Vero toxins (Shiga-like toxins) produced by enterohemorrhagic Escherichia coli (verocytotoxin-producing E. coli). |
Search more.